Merck & Company, Inc. vs Mettler-Toledo International, I — Stock Comparison
Merck & Company, Inc. (MRK) and Mettler-Toledo International, I (MTD) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Merck & Company, Inc. narrowly edges Mettler-Toledo International, I on Q·Score (7 vs 6.7 out of 10), led by Health (7 vs 6) and Sentiment (7.1 vs 6.1). Mettler-Toledo International, I scores higher on Valuation, reflecting stronger P/E and price-target positioning. Analyst consensus targets imply greater upside for MTD (+16.0%) than for MRK (+13.9%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 19% return on equity and 14% profit margins.
Valuation metrics in line with sector peers.
Analyst Consensus
Fundamentals
Frequently Asked Questions
MRK vs MTD: which stock scores better overall?
Based on Q·Score, Merck & Company, Inc. (MRK) scores 7/10 versus Mettler-Toledo International, I (MTD) at 6.7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MRK or MTD?
Merck & Company, Inc. (MRK) scores higher on Growth (6.2/10 vs 6.1/10). Merck & Company, Inc. reports revenue growth (4.9% YoY) while Mettler-Toledo International, I reports (7.2% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MRK or MTD more attractively valued?
Mettler-Toledo International, I (MTD) scores higher on Valuation (7.5/10 vs 6.7/10). MRK trades at 11.9× P/E versus MTD at 22.3×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MRK vs MTD?
There are 27 analysts covering MRK with a consensus price target of $129.74, and 12 analysts covering MTD with a consensus target of $1327.83. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MRK or MTD?
Merck & Company, Inc. (MRK) scores higher on Quality (7.7/10 vs 7.3/10). Net profit margin: MRK at 13.6%, MTD at 21.4%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MRK or MTD?
Merck & Company, Inc. (MRK) scores higher on Financial Health (7/10 vs 6/10). Market beta: MRK at 0.22, MTD at 1.26. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MRK and MTD?
Merck & Company, Inc. (MRK) has a market capitalisation of $281.2B, while Mettler-Toledo International, I (MTD) has a market cap of $23.1B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MRK or MTD pay dividends?
MRK pays a dividend yield of 2.95%, while MTD does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →